{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T09:07:43Z","timestamp":1792919263367,"version":"4.5.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T00:00:00Z","timestamp":1652659200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T00:00:00Z","timestamp":1652659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000052","name":"NIH Office of the Director","doi-asserted-by":"publisher","award":["1R35GM118182"],"award-info":[{"award-number":["1R35GM118182"]}],"id":[{"id":"10.13039\/100000052","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Med"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Severe COVID-19 is characterized by pro-inflammatory cytokine release syndrome (cytokine storm) which causes high morbidity and mortality. Recent observational and clinical studies suggest famotidine, a histamine 2 receptor (H2R) antagonist widely used to treat gastroesophageal reflux disease, attenuates the clinical course of COVID-19. Because evidence is lacking for a direct antiviral activity of famotidine, a proposed mechanism of action is blocking the effects of histamine released by mast cells. Here we hypothesized that famotidine activates the inflammatory reflex, a brain-integrated vagus nerve mechanism which inhibits inflammation via alpha 7 nicotinic acetylcholine receptor (\u03b17nAChR) signal transduction, to prevent cytokine storm.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The potential anti-inflammatory effects of famotidine and other H2R antagonists were assessed in mice exposed to lipopolysaccharide (LPS)-induced cytokine storm. As the inflammatory reflex is integrated and can be stimulated in the brain, and H2R antagonists penetrate the blood brain barrier poorly, famotidine was administered by intracerebroventricular (ICV) or intraperitoneal (IP) routes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Famotidine administered IP significantly reduced serum and splenic LPS-stimulated tumor necrosis factor (TNF) and IL-6 concentrations, significantly improving survival. The effects of ICV famotidine were significantly more potent as compared to the peripheral route. Mice lacking mast cells by genetic deletion also responded to famotidine, indicating the anti-inflammatory effects are not mast cell-dependent. Either bilateral sub-diaphragmatic vagotomy or genetic knock-out of \u03b17nAChR abolished the anti-inflammatory effects of famotidine, indicating the inflammatory reflex as famotidine\u2019s mechanism of action. While the structurally similar H2R antagonist tiotidine displayed equivalent anti-inflammatory activity, the H2R antagonists cimetidine or ranitidine were ineffective even at very high dosages.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>These observations reveal a previously unidentified vagus nerve-dependent anti-inflammatory effect of famotidine in the setting of cytokine storm which is not replicated by high dosages of other H2R antagonists in clinical use. Because famotidine is more potent when administered intrathecally, these findings are also consistent with a primarily central nervous system mechanism of action.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s10020-022-00483-8","type":"journal-article","created":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T11:05:41Z","timestamp":1652699141000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Famotidine activates the vagus nerve inflammatory reflex to attenuate cytokine storm"],"prefix":"10.1186","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8796-5523","authenticated-orcid":false,"given":"Huan","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam J.","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dane A.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harold A.","family":"Silverman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T\u00e9a","family":"Tsaava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aisling","family":"Tynan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentin A.","family":"Pavlov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric H.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Brines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangeeta S.","family":"Chavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin J.","family":"Tracey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,16]]},"reference":[{"key":"483_CR1","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1007\/s10620-020-06430-z","volume":"65","author":"EJT Aguila","year":"2020","unstructured":"Aguila EJT, Cua IHY. Repurposed GI Drugs in the Treatment of COVID-19. Dig Dis Sci. 2020;65:2452\u20133.","journal-title":"Dig Dis Sci"},{"key":"483_CR2","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/j.1472-8206.2009.00810.x","volume":"25","author":"A Ahmadi","year":"2011","unstructured":"Ahmadi A, et al. Hepatoprotective, antinociceptive and antioxidant activities of cimetidine, ranitidine and famotidine as histamine H2 receptor antagonists. Fundam Clin Pharmacol. 2011;25:72\u20139.","journal-title":"Fundam Clin Pharmacol"},{"key":"483_CR3","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/BF02774563","volume":"21","author":"M Aono","year":"1986","unstructured":"Aono M, Moriga M, Mizuta K, Narusawa H. Cholinergic effects of histamine-H2 receptor antagonists partly through inhibition of acetylcholinesterase. Gastroenterol Jpn. 1986;21:213\u20139.","journal-title":"Gastroenterol Jpn"},{"key":"483_CR4","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1084\/jem.20011714","volume":"195","author":"TR Bernik","year":"2002","unstructured":"Bernik TR, et al. Pharmacological stimulation of the cholinergic antiinflammatory pathway. J Exp Med. 2002;195:781\u20138.","journal-title":"J Exp Med"},{"key":"483_CR5","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1111\/nmo.12792","volume":"28","author":"B Bonaz","year":"2016","unstructured":"Bonaz B, et al. Chronic vagus nerve stimulation in Crohn\u2019s disease: a 6-month follow-up pilot study. Neurogastroenterol Motil. 2016;28:948\u201353.","journal-title":"Neurogastroenterol Motil"},{"key":"483_CR6","first-page":"871","volume":"79","author":"CM Brennan","year":"2022","unstructured":"Brennan CM, et al. Oral famotidine versus placebo in non-hospitalised patients with COVID-19: a randomised, double-blind, data-intense, phase 2 clinical trial. Gut. 2022;79:871.","journal-title":"Gut"},{"key":"483_CR7","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1111\/ajt.14515","volume":"18","author":"SS Chavan","year":"2018","unstructured":"Chavan SS, Ma P, Chiu IM. Neuro-immune interactions in inflammation and host defense: Implications for transplantation. Am J Transplant. 2018;18:556\u201363.","journal-title":"Am J Transplant"},{"key":"483_CR8","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/0009-2797(93)90116-G","volume":"86","author":"TL Ching","year":"1993","unstructured":"Ching TL, Haenen GR, Bast A. Cimetidine and other H2 receptor antagonists as powerful hydroxyl radical scavengers. Chem Biol Interact. 1993;86:119\u201327.","journal-title":"Chem Biol Interact"},{"key":"483_CR9","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/0922-4106(94)90123-6","volume":"268","author":"TL Ching","year":"1994","unstructured":"Ching TL, de Jong J, Bast A. Structural characteristics of histamine H2 receptor antagonists that scavenge hypochlorous acid. Eur J Pharmacol. 1994;268:89\u201393.","journal-title":"Eur J Pharmacol"},{"key":"483_CR10","first-page":"e50326","volume":"34","author":"SL DeVos","year":"2013","unstructured":"DeVos SL, Miller TM. Direct intraventricular delivery of drugs to the rodent central nervous system. J vis Exp. 2013;34:e50326.","journal-title":"J vis Exp"},{"key":"483_CR11","doi-asserted-by":"publisher","first-page":"104","DOI":"10.3389\/fnins.2018.00104","volume":"12","author":"G Dezfuli","year":"2018","unstructured":"Dezfuli G, et al. Subdiaphragmatic vagotomy with pyloroplasty ameliorates the obesity caused by genetic deletion of the melanocortin 4 receptor in the mouse. Front Neurosci. 2018;12:104.","journal-title":"Front Neurosci"},{"key":"483_CR12","first-page":"1","volume":"89","author":"M Ennis","year":"2020","unstructured":"Ennis M, Tiligada K. Histamine receptors and COVID-19. Inflamm Res. 2020;89:1\u20139.","journal-title":"Inflamm Res"},{"key":"483_CR13","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1053\/j.gastro.2020.05.053","volume":"159","author":"DE Freedberg","year":"2020","unstructured":"Freedberg DE, et al. Famotidine Use Is Associated With Improved Clinical Outcomes in Hospitalized COVID-19 Patients: A Propensity Score Matched Retrospective Cohort Study. Gastroenterology. 2020;159:1129-1131.e1123.","journal-title":"Gastroenterology"},{"key":"483_CR14","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1080\/1547691X.2021.1875085","volume":"18","author":"AG Gauthier","year":"2021","unstructured":"Gauthier AG, et al. From nicotine to the cholinergic anti-inflammatory reflex - Can nicotine alleviate the dysregulated inflammation in COVID-19? J Immunotoxicol. 2021;18:23\u20139.","journal-title":"J Immunotoxicol"},{"key":"483_CR15","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1152\/physrev.00043.2007","volume":"88","author":"HL Haas","year":"2008","unstructured":"Haas HL, Sergeeva OA, Selbach O. Histamine in the nervous system. Physiol Rev. 2008;88:1183\u2013241.","journal-title":"Physiol Rev"},{"key":"483_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118102","volume":"257","author":"A Jafarzadeh","year":"2020","unstructured":"Jafarzadeh A, Chauhan P, Saha B, Jafarzadeh S, Nemati M. Contribution of monocytes and macrophages to the local tissue inflammation and cytokine storm in COVID-19: Lessons from SARS and MERS, and potential therapeutic interventions. Life Sci. 2020;257: 118102.","journal-title":"Life Sci"},{"key":"483_CR17","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1136\/gutjnl-2020-321852","volume":"69","author":"T Janowitz","year":"2020","unstructured":"Janowitz T, et al. Famotidine use and quantitative symptom tracking for COVID-19 in non-hospitalised patients: a case series. Gut. 2020;69:1592\u20137.","journal-title":"Gut"},{"key":"483_CR18","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1111\/j.1365-2125.1987.tb03261.x","volume":"24","author":"I Kagevi","year":"1987","unstructured":"Kagevi I, Thorhallsson E, Wahlby L. CSF concentrations of famotidine. Br J Clin Pharmacol. 1987;24:849\u201350.","journal-title":"Br J Clin Pharmacol"},{"key":"483_CR19","doi-asserted-by":"publisher","first-page":"8284","DOI":"10.1073\/pnas.1605635113","volume":"113","author":"FA Koopman","year":"2016","unstructured":"Koopman FA, et al. Vagus nerve stimulation inhibits cytokine production and attenuates disease severity in rheumatoid arthritis. Proc Natl Acad Sci U S A. 2016;113:8284\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"483_CR20","first-page":"45","volume":"89","author":"HY Lam","year":"2021","unstructured":"Lam HY, Tergaonkar V, Kumar AP, Ahn KS. Mast cells: Therapeutic targets for COVID-19 and beyond. IUBMB Life. 2021;89:45.","journal-title":"IUBMB Life"},{"key":"483_CR21","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1111\/j.1365-2362.1994.tb02378.x","volume":"24","author":"D Lapenna","year":"1994","unstructured":"Lapenna D, et al. H2-receptor antagonists are scavengers of oxygen radicals. Eur J Clin Invest. 1994;24:476\u201381.","journal-title":"Eur J Clin Invest"},{"key":"483_CR22","doi-asserted-by":"crossref","first-page":"5468","DOI":"10.4049\/jimmunol.152.11.5468","volume":"152","author":"I Leal-Berumen","year":"1994","unstructured":"Leal-Berumen I, Conlon P, Marshall JS. IL-6 production by rat peritoneal mast cells is not necessarily preceded by histamine release and can be induced by bacterial lipopolysaccharide. J Immunol. 1994;152:5468\u201376.","journal-title":"J Immunol"},{"key":"483_CR23","doi-asserted-by":"publisher","first-page":"218","DOI":"10.2165\/00003088-199120030-00004","volume":"20","author":"JH Lin","year":"1991","unstructured":"Lin JH. Pharmacokinetic and pharmacodynamic properties of histamine H2-receptor antagonists. Relationship between intrinsic potency and effective plasma concentrations. Clin Pharmacokinet. 1991;20:218\u201336.","journal-title":"Clin Pharmacokinet"},{"key":"483_CR24","doi-asserted-by":"crossref","unstructured":"Loffredo M, et al. (2020) The Effect of Famotidine on SARS-CoV-2 Proteases and Virus Replication. bioRxiv: 2020.2007.2015.203059.","DOI":"10.1101\/2020.07.15.203059"},{"key":"483_CR25","doi-asserted-by":"crossref","unstructured":"Malone RW, et al. (2020) COVID-19: Famotidine, Histamine, Mast Cells, and Mechanisms. Research square.","DOI":"10.21203\/rs.3.rs-30934\/v3"},{"key":"483_CR26","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","volume":"395","author":"P Mehta","year":"2020","unstructured":"Mehta P, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395:1033\u20134.","journal-title":"Lancet"},{"key":"483_CR27","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1126\/science.abb8925","volume":"368","author":"JB Moore","year":"2020","unstructured":"Moore JB, June CH. Cytokine release syndrome in severe COVID-19. Science. 2020;368:473\u20134.","journal-title":"Science"},{"key":"483_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2021.100925","volume":"297","author":"R Mukherjee","year":"2021","unstructured":"Mukherjee R, et al. Famotidine inhibits toll-like receptor 3-mediated inflammatory signaling in SARS-CoV-2 infection. J Biol Chem. 2021;297: 100925.","journal-title":"J Biol Chem"},{"key":"483_CR29","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4103\/0976-0105.177703","volume":"7","author":"AB Nair","year":"2016","unstructured":"Nair AB, Jacob S. A simple practice guide for dose conversion between animals and human. J Basic Clin Pharm. 2016;7:27\u201331.","journal-title":"J Basic Clin Pharm"},{"key":"483_CR30","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1111\/j.1600-065X.2012.01138.x","volume":"248","author":"PS Olofsson","year":"2012","unstructured":"Olofsson PS, Rosas-Ballina M, Levine YA, Tracey KJ. Rethinking inflammation: neural circuits in the regulation of immunity. Immunol Rev. 2012;248:188\u2013204.","journal-title":"Immunol Rev"},{"key":"483_CR31","first-page":"601","volume":"67","author":"P Panula","year":"2015","unstructured":"Panula P, et al. International Union of Basic and Clinical Pharmacology. XCVIII Histamine Receptors Pharmacol Rev. 2015;67:601\u201355.","journal-title":"XCVIII Histamine Receptors Pharmacol Rev"},{"key":"483_CR32","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1517\/17425247.2016.1171315","volume":"13","author":"WM Pardridge","year":"2016","unstructured":"Pardridge WM. CSF, blood-brain barrier, and brain drug delivery. Expert Opin Drug Deliv. 2016;13:963\u201375.","journal-title":"Expert Opin Drug Deliv"},{"key":"483_CR33","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1146\/annurev-immunol-042617-053158","volume":"36","author":"VA Pavlov","year":"2018","unstructured":"Pavlov VA, Chavan SS, Tracey KJ. Molecular and Functional Neuroscience in Immunity. Annu Rev Immunol. 2018;36:783\u2013812.","journal-title":"Annu Rev Immunol"},{"key":"483_CR34","first-page":"23789","volume":"3","author":"MJ Ramos-Benitez","year":"2018","unstructured":"Ramos-Benitez MJ, et al. Fh15 Blocks the Lipopolysaccharide-Induced Cytokine Storm While Modulating Peritoneal Macrophage Migration and CD38 Expression within Spleen Macrophages in a Mouse Model of Septic Shock. Sphere. 2018;3:23789.","journal-title":"Sphere"},{"key":"483_CR35","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12929-017-0370-8","volume":"24","author":"S Seemann","year":"2017","unstructured":"Seemann S, Zohles F, Lupp A. Comprehensive comparison of three different animal models for systemic inflammation. J Biomed Sci. 2017;24:60.","journal-title":"J Biomed Sci"},{"key":"483_CR36","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.ijsu.2020.08.038","volume":"82","author":"K Sharun","year":"2020","unstructured":"Sharun K, Tiwari R, Dhama J, Dhama K. Dexamethasone to combat cytokine storm in COVID-19: Clinical trials and preliminary evidence. Int J Surg. 2020;82:179\u201381.","journal-title":"Int J Surg"},{"key":"483_CR37","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.imlet.2011.08.002","volume":"141","author":"C Smuda","year":"2011","unstructured":"Smuda C, Wechsler JB, Bryce PJ. TLR-induced activation of neutrophils promotes histamine production via a PI3 kinase dependent mechanism. Immunol Lett. 2011;141:102\u20138.","journal-title":"Immunol Lett"},{"key":"483_CR38","doi-asserted-by":"publisher","first-page":"7","DOI":"10.15424\/bioelectronmed.2016.00007","volume":"3","author":"BE Steinberg","year":"2016","unstructured":"Steinberg BE, et al. Cytokine-specific Neurograms in the Sensory Vagus Nerve. Bioelectron Med. 2016;3:7\u201317.","journal-title":"Bioelectron Med"},{"key":"483_CR39","first-page":"1241","volume":"34","author":"TC Theoharides","year":"2020","unstructured":"Theoharides TC, Conti P. Dexamethasone for COVID-19? Not so fast. J Biol Regul Homeost Agents. 2020;34:1241\u20133.","journal-title":"J Biol Regul Homeost Agents"},{"key":"483_CR40","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1016\/0006-2952(93)90218-L","volume":"45","author":"JM van Zyl","year":"1993","unstructured":"van Zyl JM, Kriegler A, van der Walt BJ. Anti-oxidant properties of H2-receptor antagonists. Effects on myeloperoxidase-catalysed reactions and hydroxyl radical generation in a ferrous-hydrogen peroxide system. Biochem Pharmacol. 1993;45:2389\u201397.","journal-title":"Biochem Pharmacol"},{"key":"483_CR41","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/nature01339","volume":"421","author":"H Wang","year":"2003","unstructured":"Wang H, et al. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature. 2003;421:384\u20138.","journal-title":"Nature"},{"key":"483_CR42","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/JLB.3COVR0520-272R","volume":"108","author":"J Wang","year":"2020","unstructured":"Wang J, Jiang M, Chen X, Montaner LJ. Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: Review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts. J Leukoc Biol. 2020;108:17\u201341.","journal-title":"J Leukoc Biol"},{"key":"483_CR43","doi-asserted-by":"publisher","first-page":"3355","DOI":"10.1113\/jphysiol.2009.173054","volume":"587","author":"LA Weigand","year":"2009","unstructured":"Weigand LA, Myers AC, Meeker S, Undem BJ. Mast cell-cholinergic nerve interaction in mouse airways. J Physiol. 2009;587:3355\u201362.","journal-title":"J Physiol"},{"key":"483_CR44","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/j.1365-2222.2005.02136.x","volume":"35","author":"PJ Wolters","year":"2005","unstructured":"Wolters PJ, et al. Tissue-selective mast cell reconstitution and differential lung gene expression in mast cell-deficient Kit(W-sh)\/Kit(W-sh) sash mice. Clin Exp Allergy. 2005;35:82\u20138.","journal-title":"Clin Exp Allergy"},{"key":"483_CR45","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.apsb.2020.02.008","volume":"10","author":"C Wu","year":"2020","unstructured":"Wu C, et al. Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods. Acta Pharmaceutica Sinica B. 2020;10:766\u201388.","journal-title":"Acta Pharmaceutica Sinica B"},{"key":"483_CR46","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1084\/jem.20141318","volume":"212","author":"H Yang","year":"2015","unstructured":"Yang H, et al. MD-2 is required for disulfide HMGB1-dependent TLR4 signaling. J Exp Med. 2015;212:5\u201314.","journal-title":"J Exp Med"},{"key":"483_CR47","doi-asserted-by":"publisher","first-page":"E4843","DOI":"10.1073\/pnas.1719083115","volume":"115","author":"TP Zanos","year":"2018","unstructured":"Zanos TP, et al. Identification of cytokine-specific sensory neural signals by decoding murine vagus nerve activity. Proc Natl Acad Sci U S A. 2018;115:E4843\u201352.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"483_CR48","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.4049\/jimmunol.1801423","volume":"203","author":"T Zhang","year":"2019","unstructured":"Zhang T, et al. A Mast Cell-Specific Receptor Is Critical for Granuloma Induced by Intrathecal Morphine Infusion. J Immunol. 2019;203:1701\u201314.","journal-title":"J Immunol"}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-022-00483-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10020-022-00483-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-022-00483-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,5]],"date-time":"2023-02-05T08:52:34Z","timestamp":1675587154000},"score":1,"resource":{"primary":{"URL":"https:\/\/molmed.biomedcentral.com\/articles\/10.1186\/s10020-022-00483-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,16]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["483"],"URL":"https:\/\/doi.org\/10.1186\/s10020-022-00483-8","relation":{},"ISSN":["1076-1551","1528-3658"],"issn-type":[{"value":"1076-1551","type":"print"},{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,16]]},"assertion":[{"value":"5 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"HY, SSC and KJT are co-inventors of a patent application (Role of the central nervous nerve system and vagus nerve signaling in famotidine-mediated anti-inflammatory effects). All other authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"57"}}